← FDA Drug Approvals (Drugs@FDA)

BYFAVO

NDA · New Drug Application · Sponsor: ACACIA · Approved 2020-07-02

Drug application

FDA Application #

NDA212295

Application type

New Drug Application

Brand name

BYFAVO

Generic name

REMIMAZOLAM BESYLATE

Active ingredients

REMIMAZOLAM BESYLATE

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

ACACIA

Manufacturer

Acacia Pharma, Ltd.

First approval

2020-07-02

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown